Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,433 | 15,759 | 17,948 | 34,568 | 14,856 |
| Marketable Securities | 8,516 | 37,007 | 83,940 | 29,014 | 62,206 |
| Receivables | 6,255 | 8,313 | 9,319 | 8,669 | 7,613 |
| Inventories | 19,475 | 19,587 | 22,892 | 26,429 | 32,453 |
| TOTAL | $60,568 | $85,611 | $140,118 | $104,537 | $122,575 |
| Non-Current Assets | |||||
| PPE Net | 24,863 | 25,279 | 23,345 | 21,266 | 20,263 |
| Intangibles | 30,021 | 31,734 | 33,974 | 35,766 | 114,840 |
| Other Non-Current Assets | 13,912 | 15,371 | 16,967 | 20,335 | 13,703 |
| TOTAL | $68,796 | $72,384 | $74,286 | $77,367 | $148,806 |
| Total Assets | $129,364 | $157,995 | $214,404 | $181,904 | $271,381 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,734 | 9,844 | 10,384 | 15,369 | 11,912 |
| Accrued Expenses | 5,530 | 11,028 | 8,089 | 11,552 | 8,316 |
| Other current liabilities | 1,147 | 6,095 | 9,317 | 10,811 | 10,978 |
| TOTAL | $37,175 | $58,506 | $100,028 | $40,194 | $33,499 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8,288 | 13,143 | 14,634 | 19,116 | 19,522 |
| TOTAL | $11,852 | $16,718 | $18,219 | $22,711 | $23,126 |
| Total Liabilities | $49,027 | $75,224 | $118,247 | $62,905 | $56,625 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,436 | 1,117 | 913 | 649 | 590 |
| Common Shares | 7 | 6 | N/A | 3 | 3 |
| Retained earnings | -628,854 | -612,630 | -581,208 | -537,317 | -424,751 |
| Other shareholders' equity | -3 | -16 | 23 | -93 | -310 |
| TOTAL | $80,337 | $82,771 | $96,157 | $118,999 | $214,756 |
| Total Liabilities And Equity | $129,364 | $157,995 | $214,404 | $181,904 | $271,381 |